保健 - 第105期 - page 42
42
CDK6
ٙཀ
༺ڌ
πίձ̈ତ
CDI
༺ڌ
ʔԑձ߉ᜊdԷ
ν༰εԈՑ
Ink4
̰ٙ
ݺ
e
Kip
ўඎٙಯˇfவேԑ˸
ϓ໕ᆯ
ߤ
ٙ೯͛ձ೯࢝f
ڐ
ϋӺ೯ତdӿᐖٙ೯͛ၾ
ߤ
ಂሜછɰϞɓ
֛ᗫ
ڷ
fɔӿष
ݭ
ᙳ੭٫੬Ϟɔӿष
ݭ
HBV
Υɝ
Cycline A
ਿΪʕ৷
༺ڌ
f
༺ڌ
̈ٙలΥஐͣॹ˶࿁
Cycline A
ٙॎᕸdʔঐࠥ༆
Ͼܵᚃ೯౨Ъ͜f
ژذ
ɽ
ක§dԴ
ߤ
ಂҞආɝʱ
ಂdኬ
ߧ
ߤ
ೌືՓήᄣ
ಟϾ
ߧ
ᐖf
Ϥ̮dӺᒔ೯ତdίɛᗳ
Ԫ໗ᐖձ໘໕ᆯઃ٫ʕdϞ
ࣛ̈ତ
CDK
ʱɿձ
Cyc l i ne
A
e
B
e
D
e
E
ഃٙਿΪٙ
ڌ
༺ɪʺdνઃ٫ٙ
Cycline D
ٙ
༺ڌ
Ⴣ৷͍੬٫f
Ўಿष
ϞӺႩ
މ
dЎಿषࣛึ̰̘е
ޥ
̌ঐ݊͟ช
ݑ
Ўಿष
ݭ
HIV
ࣛd̙Դ
T
ߤ
CDK1
ɪٙऄაಞਿ
ཀʱᐟაʷϾ̰
ݺ
dԨԴ
Cycline B
ጐၳf
Cdk1
݊
ߤ
ආɝ
M
ಂٙ˴
ࠅ
ዧ㺛d
Cycline B
ٙጐၳ
ۆ
݊ආɝ
M
ಂٙ̀
ࠅ
ૢfΪϤd
HIV
ช
ݑ
ึிϓ
ߤ
ಂ৾व
ί
G2
ಂϾʔঐආɝ
M
ಂd௰ኬ
ߧ
T
ߤ
࡙ɳd̰̘
е
ޥ
̌ঐf
সϼ
সϼɰМᎇ
ߤ
ᄣಟٙतᅄᜊʷfνᎇ䋠ϋᙧٙᄣ
ڗ
d
ߤ
ಂ
ܓڗ
ᜑַ
ڗ
f
ߤ
ʱ
ܓ
ᜑഹᜊ
࿔fՉࡡΪ˴
ࠅ
݊
G1
ಂᜑַ
ڗ
fίসϼٙ
ߤ
ʕd
Cdk2
e
G2-ycline(CyclineA
e
B)
ഃٙ
༺ڌ
ࠥЭfᒔϞ
Ⴉ
މ
dসϼձ
ߤ
CDI
ཀ
༺ڌ
Ϟᗫf
ഥʃ၍ගሯषᜊ
ഥʃ၍ɪͤ
ߤ
ึաՑε၇Ϊ९ٙฦෆdˏৎʃ၍
ගሯ
ߤ
ٙᄣಟe
ࡌ
ూձᕸϥdΝࣛМϞɓӻΐ
ߤ
ಂሜછஐͣٙɪሜfഥॹАฦෆ
ܝ
dՉ̮
ᄣಟ
ߤ
ࣨҤࡡ
(PCNA)
§
ݑ
Ѝජ
ߤ
Ԙᄣεd
ԨМϞ
CyclineD1
e
D3
e
B
e
A
ўඎʿ
CDK4
e
CDK2
ஐͣўඎʿ
ݺ
ٙᄣ̋f
ߤ
ಂஐͣԱ፠ዧ㺛ҵՓΪɿ
(CDI)
f
Չʕd
CDK
݊
ߤ
ಂሜືٙʕːᐑືd
Cycline
݊
CDK
͍ٙሜືΪɿd
CDI
݊
CDK
ٙҵՓΪɿdஷཀ
ၾ
CDK
ڢ
ᄆഐΥϾҵՓ
CDK
ݺ
ٙd݊ၾ
cycline-
CDK
Ъ͜࿁Ҥٙࠠ
ࠅ
ዚՓʘɓf
Ԫਗ
ي
ߤ
ٙ
CDI
˴
ࠅ
̍
ܼ
Ink4(
ܼ̍
P16
e
P15
e
P18
ʿ
P19)
e
Kip(
ܼ̍
p21
e
p27
e
p57)
ʿ
GADD45
ഃf
ה
˸Ϟɛਗ਼Ϥɧ٫ˢఏႭd
CDK
ʱɿ̙˸ൖ
މ
ˏᏗd
Cycline
̙ൖ
މ
ژذ
d
CDI
̙ൖ
މ
ۀ
ԓf
ߤ
ಂٙ
༶Ъdɧ٫ॹɓʔ̙f
細胞週期調控異常與疾病
ߤ
ಂሜછମ੬̙ኬ
ߧ
ߤ
ᄣಟཀ
אܓ
ߤ
ᄣಟॹd
Շ٫ேึኬ
ߧ
ɓԬशषٙ೯͛f˸ɨɓԬᗫ
शषၾ
ߤ
ಂᗫ
ڷ
ٙజ༸f
細胞增殖過度
ၾ
ߤ
ᄣಟཀ
ܓ
Ϟᗫٙशषܼ̍໕ᆯeЎಿषeস
ϼeഥʃ၍ගሯशषeਗএഎᅵʷeᗳࠬ᐀
ޒ
ᗫື
ف
eӿeഥᜄၪʷe
ۃ
ΐ໗٭ɽeࡡ೯Аʃ
ؐᄣεसeૄ
ߎ
ߤ
ᄣεसeვ࢜षഃf
໕ᆯ
໕ᆯ
ߤ
ٙᄣಟಂၾ͍੬
ߤ
Чfேܼ̍
G1
ಂe
S
ಂe
G2
ಂձ
M
ಂfՉʕ
S
e
G2
e
M
ಂ༰dಂٙ
ڗ
ɰᎇ
G1
ಂϾମfཀ̘Ⴉ
໕މ
ᆯ
ߤ
ᄣಟ༰Ҟ݊
͟Չ
ߤ
ಂ༰dତί೯ତഒɽεᅰɛ໕ᆯ
ٙ
ߤ
ಂʔසʔˢΝᗳଡ଼͍ٙ੬
ߤ
ಂdϾ
݊Ν
ڗ༰א
dʕࡡΪɰ݊
G1
ಂᜊ
ڗ
fν͍੬
၍ɪͤٙ
ߤ
ಂ
މ
144
ʃࣛd၍ᐖ
މ
250.8
ʃࣛf
ߞ
ɪͤ
މ
66
ʃࣛd
ߞ
ᐖ
މۆ
80.0
ʃࣛf
ͦ
ۃ
Ⴉ
މ
d໕ᆯٙ೯͛ၾ
Cyclins
ٙཀඎ
༺ڌ
e
CDK
ٙᄣεe
CDI
༺ڌ
ʔԑձ߉ᜊϞᗫf
Ϊ
މ
Ӻ೯ତdԪ໗ᐖe
ߞ
ᐖe༸ᐖϞ
Cy c l i n e
D1
ٙཀ
༺ڌܓ
fί໕ᆯ
ߤ
ʕᒔ̙˸ԈՑ
CDK4
ձ
專題探索
1...,32,33,34,35,36,37,38,39,40,41
43,44,45,46,47,48,49,50,51,52,...84